FCG
ABBV icon

Fielder Capital Group’s AbbVie ABBV Stock Holding History

Fielder Capital Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$637K Buy
2,532
+43
+2% +$9.25K 0.14% 111
2026
Q1 		$541K Buy
2,489
+14
+0.6% +$3.11K 0.12% 119
2025
Q4 		$566K Sell
2,475
-16
-0.6% -$3.65K 0.12% 106
2025
Q3 		$577K Sell
2,491
-25
-1% -$5.09K 0.13% 99
2025
Q2 		$467K Buy
2,516
+102
+4% +$19K 0.12% 109
2025
Q1 		$506K Buy
2,414
+32
+1% +$6.22K 0.15% 92
2024
Q4 		$423K Buy
2,382
+113
+5% +$20.8K 0.13% 112
2024
Q3 		$448K Buy
2,269
+14
+0.6% +$2.61K 0.15% 98
2024
Q2 		$387K Buy
2,255
+77
+4% +$12.8K 0.15% 95
2024
Q1 		$397K Buy
2,178
+12
+0.6% +$2.07K 0.18% 86
2023
Q4 		$336K Buy
+2,166
New +$316K 0.2% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fielder Capital Group's ABBV Position: Q2 2026 in Review

Fielder Capital Group increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $9.25K and bringing the position to 2,532 shares worth $637K. The position accounts for 0.14% of the portfolio, ranked #111.

Fielder Capital Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Fielder Capital Group held 2,532 shares of AbbVie worth $637K as of Q2 2026.
  • Fielder Capital Group bought 43 AbbVie shares in Q2 2026, an estimated $9.25K.
  • AbbVie made up 0.14% of Fielder Capital Group's portfolio in Q2 2026, its #111 holding.
  • Fielder Capital Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fielder Capital Group's 13F filing for Q2 2026, filed 6 Aug 2026.